TY - JOUR AU - Afdhal, N. AU - Zeuzem, S. AU - Kwo, P. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402454 DO - 10.1056/NEJMoa1402454 ID - Afdhal2014 ER - TY - JOUR AU - Afdhal, N. AU - Reddy, K. R. AU - Nelson, D. R. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1316366 DO - 10.1056/NEJMoa1316366 ID - Afdhal2014 ER - TY - JOUR AU - Sulkowski, M. S. AU - Gardiner, D. F. AU - Rodriguez-Torres, M. PY - 2014 DA - 2014// TI - Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1306218 DO - 10.1056/NEJMoa1306218 ID - Sulkowski2014 ER - TY - JOUR AU - Butt, A. A. AU - Yan, P. AU - Shaikh, O. S. AU - Chung, R. T. AU - Sherman, K. E. PY - 2016 DA - 2016// TI - study E. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13103 DO - 10.1111/liv.13103 ID - Butt2016 ER - TY - JOUR AU - Butt, A. A. AU - Yan, P. AU - Shaikh, O. S. AU - Chung, R. T. AU - Sherman, K. E. PY - 2016 DA - 2016// TI - Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13036 DO - 10.1111/liv.13036 ID - Butt2016 ER - TY - JOUR AU - Ioannou, G. N. AU - Beste, L. A. AU - Chang, M. F. PY - 2016 DA - 2016// TI - Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System JO - Gastroenterology VL - 151 UR - https://doi.org/10.1053/j.gastro.2016.05.049 DO - 10.1053/j.gastro.2016.05.049 ID - Ioannou2016 ER - TY - JOUR AU - Butt, A. A. AU - Ren, Y. AU - Marks, K. AU - Shaikh, O. S. AU - Sherman, K. E. PY - 2017 DA - 2017// TI - Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES JO - Aliment Pharmacol Ther VL - 45 UR - https://doi.org/10.1111/apt.13837 DO - 10.1111/apt.13837 ID - Butt2017 ER - TY - JOUR AU - Butt, A. A. AU - Ren, Y. AU - Puenpatom, A. AU - Arduino, J. M. AU - Kumar, R. AU - Abou-Samra, A. B. PY - 2018 DA - 2018// TI - Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study JO - Aliment Pharmacol Ther VL - 48 UR - https://doi.org/10.1111/apt.14799 DO - 10.1111/apt.14799 ID - Butt2018 ER - TY - JOUR AU - Backus, L. I. AU - Belperio, P. S. AU - Shahoumian, T. A. AU - Mole, L. A. PY - 2019 DA - 2019// TI - Impact of sustained Virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease JO - Hepatology VL - 69 UR - https://doi.org/10.1002/hep.29408 DO - 10.1002/hep.29408 ID - Backus2019 ER - TY - JOUR AU - Mahale, P. AU - Engels, E. A. AU - Li, R. PY - 2018 DA - 2018// TI - The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection JO - Gut VL - 67 UR - https://doi.org/10.1136/gutjnl-2017-313983 DO - 10.1136/gutjnl-2017-313983 ID - Mahale2018 ER - TY - JOUR AU - Masarone, M. AU - Persico, M. PY - 2019 DA - 2019// TI - Hepatitis C virus infection and non-hepatocellular malignancies in the DAA era: a systematic review and meta-analysis JO - Liver Int VL - 39 UR - https://doi.org/10.1111/liv.14119 DO - 10.1111/liv.14119 ID - Masarone2019 ER - TY - JOUR AU - Butt, A. A. AU - Yan, P. AU - Shuaib, A. AU - Abou-Samra, A. B. AU - Shaikh, O. S. AU - Freiberg, M. S. PY - 2019 DA - 2019// TI - Direct-acting antiviral therapy for HCV infection is associated with a reduced risk of cardiovascular disease events JO - Gastroenterology VL - 156 UR - https://doi.org/10.1053/j.gastro.2018.11.022 DO - 10.1053/j.gastro.2018.11.022 ID - Butt2019 ER - TY - JOUR AU - Butt, A. A. AU - Yan, P. AU - Aslam, S. AU - Shaikh, O. S. AU - Abou-Samra, A. B. PY - 2020 DA - 2020// TI - Hepatitis C Virus (HCV) treatment with directly acting agents reduces the risk of incident diabetes: results from electronically retrieved cohort of HCV infected veterans (ERCHIVES) JO - Clin Infect Dis VL - 70 ID - Butt2020 ER - TY - JOUR AU - Stine, J. G. AU - Intagliata, N. AU - Shah, N. L. PY - 2015 DA - 2015// TI - Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis JO - Dig Dis Sci VL - 60 UR - https://doi.org/10.1007/s10620-014-3422-x DO - 10.1007/s10620-014-3422-x ID - Stine2015 ER - TY - JOUR AU - Collins, J. M. AU - Raphael, K. L. AU - Terry, C. PY - 2015 DA - 2015// TI - Hepatitis B virus reactivation during successful treatment of hepatitis C virus with Sofosbuvir and Simeprevir JO - Clin Infect Dis VL - 61 UR - https://doi.org/10.1093/cid/civ474 DO - 10.1093/cid/civ474 ID - Collins2015 ER - TY - JOUR AU - Gane, E. AU - Lawitz, E. AU - Pugatch, D. PY - 2017 DA - 2017// TI - Glecaprevir and Pibrentasvir in patients with HCV and severe renal impairment JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1704053 DO - 10.1056/NEJMoa1704053 ID - Gane2017 ER - TY - JOUR AU - Li, D. K. AU - Ren, Y. AU - Fierer, D. S. PY - 2018 DA - 2018// TI - The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: an ERCHIVES study JO - Hepatology VL - 67 UR - https://doi.org/10.1002/hep.29707 DO - 10.1002/hep.29707 ID - Li2018 ER - TY - JOUR AU - Sulkowski, M. S. AU - Chuang, W. L. AU - Kao, J. H. PY - 2016 DA - 2016// TI - No evidence of reactivation of hepatitis B virus among patients treated with Ledipasvir-Sofosbuvir for hepatitis C virus infection JO - Clin Infect Dis VL - 63 ID - Sulkowski2016 ER - TY - JOUR AU - Belperio, P. S. AU - Shahoumian, T. A. AU - Mole, L. A. AU - Backus, L. I. PY - 2017 DA - 2017// TI - Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29135 DO - 10.1002/hep.29135 ID - Belperio2017 ER - TY - JOUR AU - Conti, F. AU - Buonfiglioli, F. AU - Scuteri, A. PY - 2016 DA - 2016// TI - Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals JO - J Hepatol VL - 65 UR - https://doi.org/10.1016/j.jhep.2016.06.015 DO - 10.1016/j.jhep.2016.06.015 ID - Conti2016 ER - TY - JOUR AU - Reig, M. AU - Marino, Z. AU - Perello, C. PY - 2016 DA - 2016// TI - Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy JO - J Hepatol VL - 65 UR - https://doi.org/10.1016/j.jhep.2016.04.008 DO - 10.1016/j.jhep.2016.04.008 ID - Reig2016 ER - TY - JOUR AU - Flisiak, R. AU - Janczewska, E. AU - Lucejko, M. PY - 2018 DA - 2018// TI - Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir+/−dasabuvir+/−ribavirin in the AMBER, real-world experience study JO - J Viral Hepat VL - 25 UR - https://doi.org/10.1111/jvh.12945 DO - 10.1111/jvh.12945 ID - Flisiak2018 ER - TY - JOUR AU - Huang, P. AU - Liu, M. AU - Zang, F. PY - 2018 DA - 2018// TI - The development of hepatocellular carcinoma in HCV-infected patients treated with DAA: a comprehensive analysis JO - Carcinogenesis VL - 39 UR - https://doi.org/10.1093/carcin/bgy099 DO - 10.1093/carcin/bgy099 ID - Huang2018 ER - TY - JOUR AU - Nahon, P. AU - Layese, R. AU - Bourcier, V. PY - 2018 DA - 2018// TI - Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs JO - Gastroenterology VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.07.015 DO - 10.1053/j.gastro.2018.07.015 ID - Nahon2018 ER - TY - JOUR AU - Calvaruso, V. AU - Cabibbo, G. AU - Cacciola, I. PY - 2018 DA - 2018// TI - Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents JO - Gastroenterology VL - 155 UR - https://doi.org/10.1053/j.gastro.2018.04.008 DO - 10.1053/j.gastro.2018.04.008 ID - Calvaruso2018 ER - TY - JOUR AU - Pasha, O. AU - Luby, S. P. AU - Khan, A. J. AU - Shah, S. A. AU - McCormick, J. B. AU - Fisher-Hoch, S. P. PY - 1999 DA - 1999// TI - Household members of hepatitis C virus-infected people in Hafizabad, Pakistan: infection by injections from health care providers JO - Epidemiol Infect VL - 123 UR - https://doi.org/10.1017/S0950268899002770 DO - 10.1017/S0950268899002770 ID - Pasha1999 ER - TY - JOUR AU - Luby, S. P. AU - Qamruddin, K. AU - Shah, A. A. PY - 1997 DA - 1997// TI - The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan JO - Epidemiol Infect VL - 119 UR - https://doi.org/10.1017/S0950268897007899 DO - 10.1017/S0950268897007899 ID - Luby1997 ER - TY - JOUR AU - Ul Abideen, Z. AU - Siddique, S. AU - Nasrullah, I. PY - 2019 DA - 2019// TI - A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients JO - Eur J Gastroenterol Hepatol VL - 31 UR - https://doi.org/10.1097/MEG.0000000000001384 DO - 10.1097/MEG.0000000000001384 ID - Ul Abideen2019 ER - TY - JOUR AU - Waqar, M. AU - Khan, A. U. AU - Rehman, H. U. PY - 2014 DA - 2014// TI - Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan) JO - Eur J Gastroenterol Hepatol VL - 26 UR - https://doi.org/10.1097/MEG.0b013e328362dc3f DO - 10.1097/MEG.0b013e328362dc3f ID - Waqar2014 ER - TY - JOUR AU - Sarwar, S. AU - Tarique, S. AU - Aleem, A. AU - Khan, A. A. PY - 2019 DA - 2019// TI - Effect of adding daclatasvir in sofosbuvir-based therapy in genotype 3 hepatitis C: real-world experience in Pakistan JO - Eur J Gastroenterol Hepatol VL - 31 UR - https://doi.org/10.1097/MEG.0000000000001376 DO - 10.1097/MEG.0000000000001376 ID - Sarwar2019 ER - TY - JOUR AU - Umar, M. AU - Khaar, H. T. AU - Akhter, T. S. PY - 2016 DA - 2016// TI - Diagnosis, management and prevention of hepatitis C in Pakistan 2017 JO - J Ayub Med Coll Abbottabad VL - 28 ID - Umar2016 ER - TY - STD TI - Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents. Gastroenterology. 2017;153(4):996-1005. https://doi.org/10.1053/j.gastro.2017.06.012. Epub 2017 Jun 19. PMID:2864219. ID - ref32 ER - TY - JOUR AU - Roffi, L. AU - Redaelli, A. AU - Colloredo, G. PY - 2001 DA - 2001// TI - Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype JO - Eur J Gastroenterol Hepatol VL - 13 UR - https://doi.org/10.1097/00042737-200105000-00007 DO - 10.1097/00042737-200105000-00007 ID - Roffi2001 ER - TY - JOUR AU - Kanwal, F. AU - Kramer, J. R. AU - Ilyas, J. AU - Duan, Z. AU - El-Serag, H. B. PY - 2014 DA - 2014// TI - HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV JO - Hepatology VL - 60 UR - https://doi.org/10.1002/hep.27095 DO - 10.1002/hep.27095 ID - Kanwal2014 ER - TY - JOUR AU - Mittal, S. AU - El-Serag, H. B. AU - Sada, Y. H. PY - 2016 DA - 2016// TI - Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease JO - Clin Gastroenterol Hepatol VL - 14 UR - https://doi.org/10.1016/j.cgh.2015.07.019 DO - 10.1016/j.cgh.2015.07.019 ID - Mittal2016 ER - TY - JOUR AU - Lai, S. W. AU - Chen, P. C. AU - Liao, K. F. AU - Muo, C. H. AU - Lin, C. C. AU - Sung, F. C. PY - 2012 DA - 2012// TI - Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study JO - Am J Gastroenterol VL - 107 UR - https://doi.org/10.1038/ajg.2011.384 DO - 10.1038/ajg.2011.384 ID - Lai2012 ER - TY - JOUR AU - Morgan, R. L. AU - Baack, B. AU - Smith, B. D. AU - Yartel, A. AU - Pitasi, M. AU - Falck-Ytter, Y. PY - 2013 DA - 2013// TI - Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies JO - Ann Intern Med VL - 158 UR - https://doi.org/10.7326/0003-4819-158-5-201303050-00005 DO - 10.7326/0003-4819-158-5-201303050-00005 ID - Morgan2013 ER - TY - JOUR AU - Nahon, P. AU - Bourcier, V. AU - Layese, R. PY - 2017 DA - 2017// TI - Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications JO - Gastroenterology VL - 152 UR - https://doi.org/10.1053/j.gastro.2016.09.009 DO - 10.1053/j.gastro.2016.09.009 ID - Nahon2017 ER - TY - JOUR AU - Cacoub, P. AU - Nahon, P. AU - Layese, R. PY - 2018 DA - 2018// TI - Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients JO - Am Heart J VL - 198 UR - https://doi.org/10.1016/j.ahj.2017.10.024 DO - 10.1016/j.ahj.2017.10.024 ID - Cacoub2018 ER - TY - JOUR AU - Tzartzeva, K. AU - Obi, J. AU - Rich, N. E. PY - 2018 DA - 2018// TI - Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis JO - Gastroenterology VL - 154 UR - https://doi.org/10.1053/j.gastro.2018.01.064 DO - 10.1053/j.gastro.2018.01.064 ID - Tzartzeva2018 ER - TY - JOUR AU - Singal, A. AU - Volk, M. L. AU - Waljee, A. PY - 2009 DA - 2009// TI - Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis JO - Aliment Pharmacol Ther VL - 30 UR - https://doi.org/10.1111/j.1365-2036.2009.04014.x DO - 10.1111/j.1365-2036.2009.04014.x ID - Singal2009 ER -